10-KPeriod: FY2004

DANAHER CORP /DE/ Annual Report, Year Ended Dec 31, 2004

Filed March 7, 2005For Securities:DHR

Summary

Danaher Corporation's 2004 10-K filing reveals a year of significant growth, primarily driven by strategic acquisitions that expanded its presence in the Medical Technology sector and strengthened its existing segments. The company reported substantial revenue increases, demonstrating effective integration of new businesses and continued organic growth in its core Professional Instrumentation, Industrial Technologies, and Tools & Components segments. Danaher's commitment to its business system (DBS) appears to be a key driver for operational improvements and competitive positioning. Financially, the company generated strong operating cash flow, which was largely utilized for its aggressive acquisition strategy. While managing increased debt levels, Danaher maintained a solid liquidity position. Investors can note the company's continued focus on shareholder value through growth and performance, coupled with a proactive approach to managing operational efficiencies and potential market risks.

Key Highlights

  • 1Significant revenue growth in 2004, with consolidated revenues increasing approximately 30% over 2003, driven by both acquisitions (18.5% growth) and existing businesses (9% growth).
  • 2Expansion into the Medical Technology segment through major acquisitions (Radiometer, KaVo, Gendex) in 2004, establishing a new strategic line of business.
  • 3Professional Instrumentation segment became the largest, driven by strong performance in Environmental, Electronic Test, and the newly formed Medical Technology businesses.
  • 4Industrial Technologies segment showed robust growth, particularly in Motion and Product Identification businesses, aided by acquisitions.
  • 5Tools & Components segment delivered steady growth, with an 8.5% increase driven by retail hand tool product lines and the Matco business.
  • 6Strong operating cash flow generation of $1,033 million in 2004, supporting significant investment in acquisitions and capital expenditures.
  • 7Company continues to utilize the Danaher Business System (DBS) to drive continuous improvement in quality, delivery, cost, and innovation across its diverse operations.

Frequently Asked Questions

Danaher experienced significant revenue growth in 2004, with consolidated revenues increasing by approximately 30% compared to 2003. This growth was driven by a combination of factors: strategic acquisitions contributed about 18.5% of the growth, while existing businesses accounted for approximately 9% growth. Favorable currency translation, particularly the strengthening of the Euro, also contributed about 2.5% to the overall sales increase.

The company made several significant acquisitions in 2004, most notably in the Medical Technology space (Radiometer, KaVo, Gendex), which formed the core of a new Medical Technology business within the Professional Instrumentation segment. This segment became Danaher's largest. Acquisitions also bolstered the Industrial Technologies segment, particularly in Product Identification, and complemented existing businesses across other segments. The Tools & Components segment saw growth primarily from existing businesses, as no acquisitions were made in this segment during 2004.

Danaher aims to create shareholder value through three primary strategies: delivering sales growth (excluding acquisitions) that exceeds overall market growth, achieving upper quartile financial performance compared to peers, and generating upper quartile cash flow from operations. The company leverages its Danaher Business System (DBS) for continuous improvement and actively pursues strategic acquisitions that fit its existing operations or establish new business lines.

In 2004, Danaher demonstrated strong financial health with operating cash flow of $1,033 million, an increase of approximately 20% over 2003. The company held $609 million in cash and cash equivalents at year-end. While acquisitions were a significant use of cash, totaling approximately $1.6 billion in 2004, the company maintained sufficient liquidity. Debt levels increased slightly, primarily due to currency fluctuations impacting Euro-denominated debt, but remained manageable.